These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2549113)

  • 21. The effect of nalmefene on pulsatile secretion of luteinizing hormone and prolactin in men.
    Graves GR; Kennedy TG; Weick RF; Casper RF
    Hum Reprod; 1993 Oct; 8(10):1598-603. PubMed ID: 8300813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioidergic and dopaminergic effects on LH and prolactin release in pony mares at different times of the year.
    Aurich C; Parvizi N; Brunklaus D; Hoppen HO; Aurich JE
    J Reprod Fertil Suppl; 2000; (56):195-203. PubMed ID: 20681131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioidergic, dopaminergic and adrenergic regulation of LH secretion in prepubertal heifers.
    Honaramooz A; Chandolia RK; Beard AP; Rawlings NC
    J Reprod Fertil; 2000 Jul; 119(2):207-15. PubMed ID: 10864832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of pulsatile secretion of progesterone during the human luteal phase.
    Steele PA; Braund W; Judd SJ
    Clin Reprod Fertil; 1986 Apr; 4(2):117-24. PubMed ID: 3742433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of morphine and naloxone on serum levels of luteinizing hormone and prolactin in prepubertal male and female rats.
    Ieiri T; Chen HT; Meites J
    Neuroendocrinology; 1979; 29(4):288-92. PubMed ID: 514456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
    Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
    J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
    Braund W; Roeger DC; Judd SJ
    J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progestins increase endogenous opioid peptide activity in postmenopausal women.
    Casper RF; Alapin-Rubillovitz S
    J Clin Endocrinol Metab; 1985 Jan; 60(1):34-6. PubMed ID: 3155455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do endogenous opioid peptides mediate the effects of photoperiod on release of luteinizing hormone and prolactin in ovariectomized ewes?
    Schillo KK; Kuehl D; Jackson GL
    Biol Reprod; 1985 May; 32(4):779-87. PubMed ID: 4005347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone.
    Melis GB; Paoletti AM; Gambacciani M; Mais V; Fioretti P
    Neuroendocrinology; 1984 Jul; 39(1):60-3. PubMed ID: 6087184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
    Tortonese DJ
    Endocrinology; 1999 Feb; 140(2):750-7. PubMed ID: 9927302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone inhibits sulpiride-induced hyperprolactinaemia in man.
    Bernini GP; Pedrinelli R; Salvetti A; Franchi F; Luisi M
    Eur J Clin Invest; 1985 Oct; 15(5):272-5. PubMed ID: 3935458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 Mar; 50(3):427-30. PubMed ID: 7358828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP; Skupny A
    J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nocturnal naloxone fails to reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Foster CM; Brown MB; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1147-51. PubMed ID: 7962287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sodium valproate on luteinizing hormone secretion in pre- and postmenopausal women and its modulation by naloxone infusion.
    Popovic V; Spremovic-Radjenovic S; Eric-Marinkovic J; Grossman A
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2520-4. PubMed ID: 8675571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of testosterone infusion and naloxone on luteinizing hormone secretion in normal men.
    Kletter GB; Foster CM; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1215-9. PubMed ID: 1430081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that a decrease in opioid tone on proestrus changes the episodic pattern of luteinizing hormone (LH) secretion: implications in the preovulatory LH hypersecretion.
    Allen LG; Hahn E; Caton D; Kalra SP
    Endocrinology; 1988 Mar; 122(3):1004-13. PubMed ID: 3125034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.